Tiam Antibodies

Santa Cruz Biotechnology features a diverse variety of Tiam monoclonal antibodies for advanced research in cell signaling and cancer biology. Tiam Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tiam, or T-lymphoma invasion and metastasis 1, is a guanine nucleotide exchange factor that plays a crucial role in regulating cell migration and invasion through interaction with Rho GTPases. Tiam significantly influences cancer progression by affecting the epithelial-mesenchymal transition (EMT) and contributing to the metastatic potential of tumor cells. Research has shown that Tiam expression levels correlate with cancer progression in multiple tumor types. Understanding Tiam's molecular mechanisms and signaling pathways is essential for developing targeted therapies and improving treatment strategies for various cancers. Investigating Tiam's role in cell motility provides valuable insights into tumor metastasis mechanisms. Researchers can explore cellular migration patterns and metastatic behavior through detailed analysis of Tiam activity. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge cancer research, enabling scientists to advance our understanding of tumor progression and develop more effective therapeutic approaches.